Compression Works Revenue and Competitors
Estimated Revenue & Valuation
- Compression Works's estimated annual revenue is currently $2.5M per year.
- Compression Works's estimated revenue per employee is $226,909
Employee Data
- Compression Works has 11 Employees.
- Compression Works grew their employee count by 0% last year.
Compression Works's People
Name | Title | Email/Phone |
---|---|---|
1 | President & CEO | Reveal Email/Phone |
2 | VP, Corporate Development | Reveal Email/Phone |
3 | Global Marketing Director | Reveal Email/Phone |
Compression Works Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $25.6M | 67 | 31% | N/A | N/A |
#2 | $32M | 84 | 8% | N/A | N/A |
#3 | $2.5M | 11 | 0% | N/A | N/A |
#4 | $18.1M | 53 | 33% | N/A | N/A |
#5 | $3.5M | 21 | 11% | $200K | N/A |
#6 | $15M | 70 | 4% | N/A | N/A |
#7 | $32M | 84 | 8% | N/A | N/A |
#8 | $11.8M | 39 | 56% | N/A | N/A |
#9 | $1.7M | 27 | 8% | N/A | N/A |
What Is Compression Works?
Hemorrhage Stops Here™\n\nSaving lives with innovative, hemorrhage-control solutions… on the battlefields and in our communities.\n\nCompression Works is the manufacturer of the Abdominal Aortic and Junctional Tourniquet-Stabilized (AAJT-S). This innovative, life-saving device is the only device to provide stable and complete occlusion of blood flow to the lower extremities, pelvis and upper extremities. A solution for pelvic and junctional penetrating trauma, bleeding from pelvic fractures and postpartum hemorrhaging, the device is currently in use in over a dozen countries around the world. With the AAJT-S, wounds to the pelvis, inguinal, and axilla region are now preventable causes of death.
keywords:N/AN/A
Total Funding
11
Number of Employees
$2.5M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.7M | 11 | N/A | N/A |
#2 | $1M | 11 | -27% | N/A |
#3 | $1M | 11 | 10% | N/A |
#4 | $1M | 11 | 22% | N/A |
#5 | $1.7M | 11 | 22% | N/A |